Table 1.
Laboratory findings before and after MSCs therapy.
Variables | The 1th time |
The 2th time |
The 3th time |
||||||
---|---|---|---|---|---|---|---|---|---|
Before | After | p | Before | After | p | Before | After | p | |
WBC (*109/L) | 6.3 ± 1.8 | 6.5 ± 2.0 | 0.475 | 7.1 ± 2.6 | 6.5 ± 1.6 | 0.315 | 6.0 ± 0.5 | 6.2 ± 0.7 | 0.186 |
CRP (mg/L) | 1.8(0.5,8.9) | 0.9(0.5,6.9) | 0.287 | 0.6(0.5,6.8) | 0.9(0.5,3.7) | 0.678 | 0.8(0.5,1.1) | 1.0(0.5,3.4) | 0.484 |
PCT (ng/ml) | 0.07(0.05,0.1) | 0.07(0.05,0.09) | 0.113 | 0.08±0.05 | 0.08(0.06,0.1) | 0.221 | 0.07±0.02 | 0.07±0.02 | 0.108 |
IL-6 (pg/ml) | 5.5(2.6,10.9) | 5.2(2.8,9.1) | 0.775 | 8.1 ± 6.1 | 6.9(3.9,15.0) | 0.296 | 8.6 ± 6.0 | 7.1(3.0,13.6) | 0.721 |
LAC (mmol/L) | 1.8 ± 0.7 | 2.9 ± 1.2 | 0.030 | 2.1 ± 1.2 | 3.5 ± 1.5 | 0.000 | 3.0 ± 0.4 | 3.4 ± 1.2 | 0.782 |
ALT (U/L) | 27.3(19.5,50.6) | 30.0 ± 15.1 | 0.085 | 35.0 ± 17.1 | 31.7 ± 20.7 | 0.472 | 34.0 ± 16.4 | 32.4 ± 15.2 | 0.139 |
Cr (μmol/L) | 54.6 ± 11.8 | 56.1 ± 12.0 | 0.293 | 55.8 ± 17.8 | 55.5 ± 19.5 | 0.867 | 65.6 ± 21.5 | 65.5 ± 18.2 | 0.923 |
cTnT (ng/ml) | 12.7 ± 6.8 | 18.3 ± 13.4 | 0.029 | 9.6 ± 6.5 | 10.2 ± 9.2 | 0.686 | 2.3 ± 3.0 | 5.2 ± 2.1 | 0.132 |
CK-MB(μmol/L) | 1.1(0.6,1.8) | 0.9(0.8,1.9) | 0.861 | 0.7 ± 0.2 | 0.8 ± 0.2 | 0.031 | 0.6 ± 0.2 | 0.3 ± 0.3 | 0.135 |
IgM (s/co) | 0.8(0.5,1.7) | 0.6(0.4,0.7) | 0.343 | 0.8 ± 0.8 | 0.5(0.1,3.8) | 0.715 | 0.5 ± 0.3 | 0.4 ± 0.2 | 0.424 |
IgG (s/co) | 20.7(13.5,80.8) | 32.4 ± 20.7 | 0.214 | 33.5 ± 28.3 | 27.2 ± 26.0 | 0.123 | 18.8 ± 15,3 | 13.2 ± 7.6 | 0.461 |
Values are presented as mean ± SD or median (P25, P75). WBC, White blood cells; CRP, C-reaction protein; PCT, procalcitonin; IL-6, interleukin-6; LAC, lactate; ALT, alanine aminotransferase; Cr, creatinine; cTnT, cardiac troponin T; CK-MB, creatine kinase-MB.